subscribe

Contact Jackie to advertise here - £75/month

 

...........................

 

Unisharp

 

...........................

 

ESH logo

 

ESH Community offer discounted charitably supported placements!

 

We're a small not-for-profit residential drug and alcohol rehab centre providing medically monitored detox and rehabilitation services. We want to continue to make our service affordable and accessible so we're once again able to offer a limited number of discounted charitably supported placements.

 

Give us a call see how we can help.

 

...........................

 

University West of Scotland Contemporary Drug & Alcohol Studies


UWS’s Postgraduate Programme in Contemporary Drug & Alcohol Studies (CDAS) is a fantastic course for people looking to study, work and research in this area, and for practitioners looking to develop their practice. The course is grounded in the UK and global in outlook. Students are supported to:

- examine social, cultural, and political influences on drug/alcohol use and policies,

- explore the evidence for responses that reduce harms and support recovery,

- undertake a work-based placement to apply learning into practice.

We offer a range of study options and a supportive student-centred learning environment. For more information email Programme Lead April.Shaw@uws.ac.uk or click on this link

 

...........................

 

Chemsex 2026

 

With a focus on Practice, the 3rd London Chemsex Conference is a rare space where practitioners can meet, learn and share. If you work in chemsex, drugs and alcohol, sexual health, mental health, emergency care, or commissioning, this is a serious day for serious practice. Conference delivered by the Gay Men’s Health Collective (GMHC) in partnership with Antidote, the UK’s only LGBTQ+ run and targeted drug and alcohol support service. GMHC’s health and wellbeing project has had a focus on chemsex harm reduction for 15 years. £80. Early bird £60. Click here for tickets and more.

...........................

 

Comments / sponsorship

If you have any comments about DrugWise Daily or to find out about sponsorship please contact the Editor: Jackie Buckle

 

 

Disclaimer

DrugWise Daily, X, BlueSky and Facebook are intended purely as current awareness resources. DrugWise Daily does not endorse nor guarantee the accuracy of the information provided by external sources/links, and accepts no responsibility or liability for any consequences arising from the use of such data. See our editorial policy here

 

subscribe

 

We are pleased to present DrugWise Daily in association with DDN

 

DDN

 

and


Drug and Alcohol Findings

 

Anti-Stigma Network

 


Thank you to our gold sponsors:

 

 

Forward Trust logo

 

 

YMCA logo

 

 

Thank you to our silver sponsors:

 

APCDLOlogo

 

drinkaware

 

ESH logo

 

 

 

Could you sponsor DrugWise Daily? Your logo will appear here with a link to your website. Please Email
Harry Shapiro

 

 

 

DrugWise Daily

8th June 2026

 

Thank you to our Premium sponsors:

 

CGL logo

 

Phoenix Futures logo

Waythrough logo

WithYou

Exchange Supplies

 

Could you sponsor DrugWise Daily? Please Email Harry Shapiro to discuss

 

 

UK news

A Clear Way Forward: The Case for Better Alcohol Labelling

A Clear Way Forward represents the most comprehensive audit to date of alcohol labels in the UK and demonstrates why mandatory alcohol labelling is so needed. Looking at over 530 products, this analysis shows what information the alcohol industry prioritises, what information is missing or inconsistent between products, and where improved alcohol labelling could benefit consumers and the public | AHA, UK

The 2026 Tobacco and Vapes Act: on to the tobacco endgame

The goal of the tobacco endgame is that no one starts to smoke, that everyone who smokes is supported to quit and that reductions in consumption and profitability mean that the tobacco industry, which continues to be the main barrier to progress, ceases to be commercially viable | BMJ, UK

Harms and benefits of discussing the brain disease model of addiction in therapeutic settings

[Open access] In Devon in England, people in treatment for substance use problems were asked to imagine they were in an introductory support group which focused either on addiction as a biological vulnerability ('brain disease') or as a response to social stress. Brain-disease formulations would, they thought, lead to reduced expectations of recovery and a tendency not to try so hard to stop using | DAD, UK

Guidance for recording tobacco exposure in pregnancy in BadgerNet Maternity

Clear recording of tobacco smoking in pregnancy in electronic patient records is essential for patient management and to understand ongoing service needs and effectiveness. The current sections for recording tobacco smoking in the BadgerNet Maternity system are not clearly labelled. There is also not a separate section for recording electronic cigarette use in pregnancy | Public Health Scotland, UK

My drinking days are over - here are my tips for an alcohol-free World Cup

Sam O'Brien West, 32, always knew he was a problem drinker, often the drunkest person in the room at social events. Now sober, the football fan shares his advice for having a great alcohol-free World Cup | BBC, UK

Swapping smoking for vaping in England with Vera Buss and Leonie Brose - podcast

In this episode, Annika Theodoulou speaks to Dr Vera Buss, a Senior Research Fellow at University College London, and Professor Leonie Brose, a Professor of Addictions & Public Health at King's College London, UK. The interview covers Vera and Leonie’s research article examining the association between the national ‘Swap to Stop’ programme offering free vapes for smoking cessation and quit attempts in England | Addiction, UK

Forward Growing: A New Partnership with Garon Park

The Forward Trust is delighted to announce an exciting new partnership with Garon Park in Southend, launching a community initiative called Forward Growing | Forward Trust, UK

PhD and fellowship funding opportunities

We are currently inviting applications for PhD studentships and fellowships. If you have an idea that will advance the scientific understanding of addiction, and the use of this knowledge in policy and practice, please consider applying. In this round of funding, there are no limitations on the type of method, approach, population, or type of addiction in your research | SSA, UK

Future Leaders in Addiction Science

Tickets are now available for Future Leaders in Addiction Science – an event hosted by Addiction Healthcare Goals, the Medical Research Council, and the Society for the Study of Addiction that will explore the latest developments in addiction research and discuss emerging leadership pathways within the field | SSA, UK

Police to kick-off World Cup drink and drug checks

As the football tournament kicks-off on 11 June, Durham Police said officers would be increasing operations across the county | BBC, UK

Man who 'discreetly supplied' class A drugs jailed

Mohammed Bham, from Gloucester and of no fixed address, was sentenced to seven years and three months in prison at Gloucester Crown Court on Tuesday. He had previously admitted to Class A drug and criminal property offences | BBC, UK

 

International news

Charting the decline of the fourth wave: US overdose deaths by race, ethnicity and substance involvement

[Open access] All four previously defined waves of the US overdose crisis appear to be in decline, as deaths involving illicit fentanyl, with and without stimulants, dropped sharply between 2023 and 2024. Concurrently, the fraction of overdose deaths involving stimulants without fentanyl and those involving xylazine continued to increase. While racial disparities in drug overdose death rates narrowed slightly, large gaps remain, with the highest overdose death rates among American Indian, Alaska Native, and Black individuals | Addiction, UK

ESCAPE syringe analysis highlights evolving patterns of injecting drug use in Europe

The latest patterns of injecting drug use in a selection of European cities are presented in a new analysis from the European Union Drugs Agency (EUDA). The findings are from the agency’s ESCAPE project, which investigates the substances used by people who inject drugs (PWID) by chemically analysing the content of used syringes. An estimated 500 000 people inject drugs in the EU, and they face elevated risks of overdose and infectious diseases | EUDA, Portugal

EUDA webinar: Conceptualising drug market-related violence

16 Jun 2026, Online. This webinar seeks to inform participants on the concept of drug market-related violence, how to conceptualise it and how to measure it | EUDA, Portugal

Help us shape EUDA Strategy 2030: public consultation opens!

The European Union Drugs Agency (EUDA) has launched a public consultation to help shape its forthcoming Strategy 2030. The consultation forms part of a broader stakeholder engagement process supporting the development of the strategy, which will define the agency’s strategic priorities for the coming years | EUDA, Portugal

Alcohol is the root of 62 diseases and a partial cause of dozens more

Dozens of diseases are partially if not entirely attributable to alcohol consumption—but many can be slowed or reversed by cutting down on or quitting drinking, according to a new review co-authored by researchers at Harvard T.H. Chan School of Public Health | Harvard TH Chan, USA

Cychlorphine Is Not the Problem

Over the course of 2026 a growing number of headlines have invited the public to panic about cychlorphine, a relatively recent addition to the drug supply that’s been implicated in overdose deaths across the country | Filter Magazine, USA

Effect of the online Rethink My Drink alcohol intervention on alcohol use and cognition in older adults in Australia: a randomised controlled trial

[Open access] 60–75-year-olds concerned about their risky drinking reduced consumption slightly but significantly more if allocated to a 36-lesson online alcohol treatment programme than to an online alcohol information booklet | Lancet, Australia

 

Blogs, comment and opinion

Psilocybin-assisted therapy for difficult-to-treat depression: underwhelming, but still vital?

Psychedelics were once, not so long ago, held up by select vocal advocates as a New Panacea for difficult-to-treat (or treatment-resistant) depression, as psychological ‘antibiotics’ that would revolutionise psychiatry. Then came the naysayers, those with vehement reservations about the science of psychoactives | Mental Elf blog, UK

Post-trial Psilocybin Access: Reflections on R (On the Application of EB)

EB whose name is protected by an anonymity order – has had anorexia nervosa since she was a teenager. It has shaped almost every aspect of her life. She has tried multiple treatments, but none of them has worked. Then, in 2022, she took part in a clinical trial investigating psilocybin as a potential treatment. For the first time, something helped. Then the trial ended, and she was left with no means of lawfully accessing the treatment | Drug Science, UK